Diamyd Medical Expands AI-Driven Screening for Type 1 Diabetes Under European ASSET Project
Stockholm, Sweden — Diamyd Medical, a biotech company specializing in precision medicine for diabetes, announced a significant milestone in its efforts…
The Pulse of AI News in Healthcare
Stockholm, Sweden — Diamyd Medical, a biotech company specializing in precision medicine for diabetes, announced a significant milestone in its efforts…
Diabetes, once considered a death sentence, has seen groundbreaking transformations in treatment and management over the past century. What began…
As of 2021, approximately 38.4 million Americans, or 11.6% of the population, were living with diabetes. This includes 29.7 million…
Imagine checking your blood pressure or screening for diabetes without stepping into a doctor’s office, pricking your finger, or strapping…